103 related articles for article (PubMed ID: 16799630)
1. ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.
Zhang JS; Gong A; Young CY
Oncogene; 2007 Jan; 26(1):111-22. PubMed ID: 16799630
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal LIM domain negatively regulates the kinase activity of LIM-kinase 1.
Nagata K; Ohashi K; Yang N; Mizuno K
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):99-105. PubMed ID: 10493917
[TBL] [Abstract][Full Text] [Related]
3. Verprolin function in endocytosis and actin organization. Roles of the Las17p (yeast WASP)-binding domain and a novel C-terminal actin-binding domain.
Thanabalu T; Rajmohan R; Meng L; Ren G; Vajjhala PR; Munn AL
FEBS J; 2007 Aug; 274(16):4103-25. PubMed ID: 17635585
[TBL] [Abstract][Full Text] [Related]
4. A C-terminal dimerization motif is required for focal adhesion targeting of Talin1 and the interaction of the Talin1 I/LWEQ module with F-actin.
Smith SJ; McCann RO
Biochemistry; 2007 Sep; 46(38):10886-98. PubMed ID: 17722883
[TBL] [Abstract][Full Text] [Related]
5. Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.
Loberg RD; Neeley CK; Adam-Day LL; Fridman Y; St John LN; Nixdorf S; Jackson P; Kalikin LM; Pienta KJ
Int J Oncol; 2005 Jun; 26(6):1699-705. PubMed ID: 15870888
[TBL] [Abstract][Full Text] [Related]
6. Actin binding LIM protein 3 (abLIM3).
Krupp M; Weinmann A; Galle PR; Teufel A
Int J Mol Med; 2006 Jan; 17(1):129-33. PubMed ID: 16328021
[TBL] [Abstract][Full Text] [Related]
7. MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta.
Woodings JA; Sharp SJ; Machesky LM
Biochem J; 2003 Apr; 371(Pt 2):463-71. PubMed ID: 12570871
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of Cdc42 through the GAP domain of RLIP participates in remodeling of the actin cytoskeleton and is involved in Xenopus gastrulation.
Boissel L; Houssin N; Chikh A; Rynditch A; Van Hove L; Moreau J
Dev Biol; 2007 Dec; 312(1):331-43. PubMed ID: 17950267
[TBL] [Abstract][Full Text] [Related]
9. Properties of an ezrin mutant defective in F-actin binding.
Saleh HS; Merkel U; Geissler KJ; Sperka T; Sechi A; Breithaupt C; Morrison H
J Mol Biol; 2009 Jan; 385(4):1015-31. PubMed ID: 19084535
[TBL] [Abstract][Full Text] [Related]
10. Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma.
Menez J; Le Maux Chansac B; Dorothée G; Vergnon I; Jalil A; Carlier MF; Chouaib S; Mami-Chouaib F
Oncogene; 2004 Apr; 23(15):2630-9. PubMed ID: 15048094
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
[TBL] [Abstract][Full Text] [Related]
12. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton.
Chen H; Bai J; Ye J; Liu Z; Chen R; Mao W; Li A; Zhou J
Cell Signal; 2007 Jun; 19(6):1315-27. PubMed ID: 17336041
[TBL] [Abstract][Full Text] [Related]
13. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.
Zhang J; Park SI; Artime MC; Summy JM; Shah AN; Bomser JA; Dorfleutner A; Flynn DC; Gallick GE
J Clin Invest; 2007 Oct; 117(10):2962-73. PubMed ID: 17885682
[TBL] [Abstract][Full Text] [Related]
14. Identification of a LIM domain-containing gene in the Cyathostominae.
Matthews JB; Johnson DR; Lazari O; Craig R; Matthews KR
Vet Parasitol; 2008 Jun; 154(1-2):82-93. PubMed ID: 18406533
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells.
Janji B; Giganti A; De Corte V; Catillon M; Bruyneel E; Lentz D; Plastino J; Gettemans J; Friederich E
J Cell Sci; 2006 May; 119(Pt 9):1947-60. PubMed ID: 16636079
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
[TBL] [Abstract][Full Text] [Related]
17. Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains.
Sawyer GM; Clark AR; Robertson SP; Sutherland-Smith AJ
J Mol Biol; 2009 Jul; 390(5):1030-47. PubMed ID: 19505475
[TBL] [Abstract][Full Text] [Related]
18. Actin-organising properties of the muscular dystrophy protein myotilin.
von Nandelstadh P; Grönholm M; Moza M; Lamberg A; Savilahti H; Carpén O
Exp Cell Res; 2005 Oct; 310(1):131-9. PubMed ID: 16122733
[TBL] [Abstract][Full Text] [Related]
19. Identification of plant cytoskeleton-interacting proteins by screening for actin stress fiber association in mammalian fibroblasts.
Abu-Abied M; Golomb L; Belausov E; Huang S; Geiger B; Kam Z; Staiger CJ; Sadot E
Plant J; 2006 Nov; 48(3):367-79. PubMed ID: 17010111
[TBL] [Abstract][Full Text] [Related]
20. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
